Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Knight Therapeutics Inc. (KHTRF)

Compare
3.9500
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT

Research Analysis

Revenue vs. Earnings

Revenue 96.86M
Earnings --

Q1'24

Q2'24

Q3'24

Q4'24

0
20M
40M
60M
80M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in CAD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6677
Avg. Estimate 87.67M97.53M398.39M436.9M
Low Estimate 79.6M93.2M395.8M425.05M
High Estimate 94.3M102.21M402.45M450.5M
Year Ago Sales 86.6M95.57M371.3M398.39M
Sales Growth (year/est) 1.23%2.05%7.30%9.67%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
KHTRF --------
S&P 500 6.92%4.87%8.58%14.16%

Upgrades & Downgrades

Maintains Raymond James: Outperform to Outperform 3/6/2024